Search
Search Results
##search.searchResults.foundPlural##
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6814PDF: 3645HTML: 753 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1301PDF: 564Suppl. Files: 346HTML: 144 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1999PDF: 1135HTML: 627 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1271PDF: 979HTML: 337 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3370PDF: 1280HTML: 2215Fi.1 Gritti.Rambaldi: 205 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3698PDF: 1443HTML: 182 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3273PDF: 1241HTML: 8105 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7965PDF: 4134HTML: 7366 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
997PDF: 988Suppl. Files: 636HTML: 128 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1083PDF: 843HTML: 238 -
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1053PDF: 617Html: 149 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1832PDF: 716HTML: 2107Untitled: 217Untitled: 153Untitled: 172Untitled: 155Untitled: 164Untitled: 179Untitled: 185 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
875PDF: 475HTML: 127Suppl. Files: 318 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1720PDF: 839HTML: 148 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1968PDF: 749HTML: 694 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3384PDF: 1292HTML: 1864Fig.1: 199Fig. 2: 208 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1912PDF: 1217HTML: 238 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2195PDF: 801HTML: 1627Figure 1: 182Table 1: 207 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2272PDF: 933HTML: 302 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2607PDF: 1611HTML: 2354Table1: 190







